West Pharmaceutical(WST) - 2022 Q3 - Earnings Call Presentation

Third-Quarter 2022 WST Q3 2022 Earnings 1 Third Quarter Overall Net Sales $686.9M | 2.8$1.59 Adjusted Diluted Earnings Per Share: $2.03 "While our base, non-COVID-19 demand continues to grow, we have had multiple constraints that impacted our financial results. Delays in expansion projects as well as customer delivery timing and mix-shift related productivity impacts resulted in lower-than-expected overall high-value product (HVP) net sales. We expect to resolve these issues in ...